Shortness of Breath: Pulmonary vs Cardiac Causes
Shortness of breath — medically termed dyspnea — is one of the most common reasons patients seek emergency and outpatient care in the United States, and its causes span two major organ systems: the lungs and the heart. Determining whether dyspnea originates from a pulmonary or cardiac source shapes every downstream decision, from diagnostic testing to treatment pathway to specialist referral. The pulmonary conditions covered across this site range from obstructive lung disease to pulmonary embolism, all of which can produce dyspnea indistinguishable from cardiac causes without systematic evaluation.
Definition and Scope
Dyspnea is defined by the American Thoracic Society (ATS) as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity" (ATS Consensus Statement on Dyspnea, American Journal of Respiratory and Critical Care Medicine, 1999). This definition deliberately separates the subjective experience from objective findings such as hypoxia or tachypnea, because patients can have severe measurable impairment without reporting breathlessness, and vice versa.
The scope of dyspnea as a clinical problem is broad. According to the National Heart, Lung, and Blood Institute (NHLBI), dyspnea is among the top 5 presenting complaints in emergency departments nationally. The differential diagnosis encompasses pulmonary causes — asthma, COPD, pulmonary embolism, pulmonary fibrosis, pulmonary hypertension, and pneumonia — and cardiac causes including heart failure, acute coronary syndrome, arrhythmia, and pericardial disease.
Understanding the regulatory context for pulmonary medicine, including how CMS and accreditation bodies structure diagnostic coding and reimbursement pathways, helps explain why systematic differentiation of pulmonary versus cardiac dyspnea is embedded in clinical quality standards.
How It Works
Pulmonary Mechanism
Pulmonary dyspnea arises when gas exchange, airflow, or respiratory mechanics are impaired. The three primary pathophysiologic pathways are:
- Increased airway resistance — Obstruction from bronchospasm (asthma) or mucus hypersecretion and airway remodeling (COPD) forces the respiratory muscles to generate greater pressure to move the same volume of air. Forced expiratory volume in 1 second (FEV1) below 80% of predicted value is a standard threshold for classifying airflow obstruction, per NHLBI spirometry interpretation guidelines.
- Impaired gas exchange — Conditions such as pulmonary fibrosis thicken the alveolar-capillary membrane, reducing diffusing capacity (DLCO). A DLCO below 40% predicted correlates with severe functional impairment (ATS/ERS Task Force on Pulmonary Function Testing, 2005).
- Vascular obstruction — Pulmonary embolism obstructs blood flow through the pulmonary vasculature, increasing dead space and triggering reflex tachypnea through J-receptor activation. The Wells score, published in the Annals of Internal Medicine, provides a structured pre-test probability framework for PE that remains widely referenced in emergency medicine protocols.
Cardiac Mechanism
Cardiac dyspnea originates primarily from elevated left ventricular filling pressures or reduced cardiac output. When the left ventricle fails, pulmonary venous pressure rises, fluid transudates into the interstitium and alveoli (pulmonary edema), and lung compliance falls. The patient must work harder to breathe, activating the same subjective sense of breathlessness as mechanical lung disease.
The distinction is mechanistic but not always clinically obvious, because both pathways produce hypoxia, tachypnea, and accessory muscle use.
Common Scenarios
Pulmonary Presentations
- Asthma exacerbation: Dyspnea is accompanied by audible wheezing, prolonged expiration, and a history of allergen or irritant exposure. Peak expiratory flow (PEF) below 50% predicted signals a severe attack per NHLBI Expert Panel Report 3 guidelines.
- COPD exacerbation: Dyspnea worsens over hours to days, typically with increased sputum production and cough. Arterial blood gas findings of hypercapnia (PaCO2 above 45 mmHg) indicate ventilatory failure.
- Pulmonary embolism: Sudden-onset dyspnea, often with pleuritic chest pain and unexplained tachycardia. The PIOPED II study found CT pulmonary angiography sensitivity of approximately 83% for PE diagnosis.
- Pulmonary hypertension: Exertional dyspnea that progresses over months, with right heart strain findings on ECG and echocardiography.
Cardiac Presentations
- Acute heart failure: Orthopnea (dyspnea worsening when supine) and paroxysmal nocturnal dyspnea are hallmark features. BNP (B-type natriuretic peptide) above 100 pg/mL has sensitivity above 90% for heart failure in the dyspneic patient, per data published in the New England Journal of Medicine (Maisel et al., 2002).
- Acute coronary syndrome: Dyspnea may be the primary complaint, particularly in diabetic patients or older adults who present without classic chest pain.
- Arrhythmia: Atrial fibrillation reduces cardiac output and can trigger acute dyspnea without any primary lung pathology.
Decision Boundaries
Differentiating pulmonary from cardiac dyspnea depends on a layered diagnostic framework rather than any single test.
| Feature | Pulmonary | Cardiac |
|---|---|---|
| Onset pattern | Often with exertion or trigger exposure | Exertional or paroxysmal nocturnal |
| Positional component | Variable | Orthopnea common |
| Associated symptoms | Wheezing, cough, sputum | Edema, palpitations |
| Spirometry | Obstructive or restrictive pattern | Usually normal unless pulmonary edema |
| Chest X-ray | Hyperinflation, infiltrates, fibrosis | Cardiomegaly, vascular redistribution |
| BNP/NT-proBNP | Usually normal | Elevated |
| ECG | Sinus tachycardia, P pulmonale | LVH, ischemic changes, arrhythmia |
The pulmonary function tests page details how spirometry, DLCO, and lung volume measurements contribute to isolating pulmonary mechanisms. For cases with overlapping findings, echocardiography combined with arterial blood gas analysis defines the predominant driver.
The ATS/ERS joint statement on dyspnea evaluation recommends a structured stepwise approach: history and physical examination first, then chest X-ray and ECG, followed by spirometry or echocardiography based on the predominant clinical hypothesis. When both systems are implicated — as in pulmonary hypertension or obesity-hypoventilation syndrome — right heart catheterization (the gold standard for hemodynamic diagnosis) is required to assign causation definitively.
References
- American Thoracic Society — Dyspnea Consensus Statement (AJRCCM 1999)
- National Heart, Lung, and Blood Institute (NHLBI)
- NHLBI Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma
- ATS/ERS Task Force on Pulmonary Function Testing (ERJ 2005)
- PIOPED II Investigators — CT Pulmonary Angiography for PE (NEJM 2006)
- Maisel et al. — BNP in Acute Dyspnea (NEJM 2002)
- Centers for Medicare & Medicaid Services (CMS)
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)